Vaccine
Volume 33, Issue 19, Pages 2197-2296 (5 May 2015)
http://www.sciencedirect.com/science/journal/0264410X/33/19

Conference report
Vaccines, our shared responsibility
Pages 2197-2202
Sonia Pagliusi, Rishabh Jain, Rajinder Kumar Suri, the DCVMN Executive Committee Group
Abstract
The Developing Countries Vaccine Manufacturers’ Network (DCVMN) held its fifteenth annual meeting from October 27–29, 2014, New Delhi, India. The DCVMN, together with the co-organizing institution Panacea Biotec, welcomed over 240 delegates representing high-profile governmental and nongovernmental global health organizations from 36 countries.
Over the three-day meeting, attendees exchanged information about their efforts to achieve their shared goal of preventing death and disability from known and emerging infectious diseases.

Special praise was extended to all stakeholders involved in the success of polio eradication in South East Asia and highlighted challenges in vaccine supply for measles-rubella immunization over the coming decades. Innovative vaccines and vaccine delivery technologies indicated creative solutions for achieving global immunization goals.

Discussions were focused on three major themes including regulatory challenges for developing countries that may be overcome with better communication; global collaborations and partnerships for leveraging investments and enable uninterrupted supply of affordable and suitable vaccines; and leading innovation in vaccines difficult to develop, such as dengue, Chikungunya, typhoid-conjugated and EV71, and needle-free technologies that may speed up vaccine delivery. Moving further into the Decade of Vaccines, participants renewed their commitment to shared responsibility toward a world free of vaccine-preventable diseases.

.

Cost–benefit of the introduction of new strategies for vaccination against pertussis in Spain: Cocooning and pregnant vaccination strategies
Original Research Article
Pages 2213-2220
María Isabel Fernández-Cano, Lluís Armadans Gil, Magda Campins Martí
Highlights
– The high incidence of pertussis in infants requires short-term preventive measures.
– Infant hospitalizations would decrease more with maternal vaccination than with cocoon strategy.
– The NNV to avoid a case would be more favorable for the pregnant vaccination approach.
– Benefit-to-cost ratio would be better for the pregnant vaccination.

.
Accounting for personal and professional choices for pandemic influenza vaccination amongst English healthcare workers
Original Research Article
Pages 2267-2272
Afrodita Marcu, Helena Rubinstein, Susan Michie, Lucy Yardley

.
Web-based intensive monitoring of adverse events following influenza vaccination in general practice
Original Research Article
Pages 2283-2288
Leontine van Balveren-Slingerland, Agnes Kant, Linda Härmark